A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies

NCT06181032 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Malignancies

Interventions

DRUG: Adebrelimab
DRUG: Apatinib
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

First Affiliated Hospital of Fujian Medical University